Dentsply Sirona (XRAY) - EV/EBITDA Multiple

Sirona Dental Systems - graphic logo of issuer XRAY

Inelastic demand for dental services provides DENTSPLY SIRONA Inc. (XRAY) with a stable revenue stream and predictable FCF. The EV/EBITDA dynamics on the GURU.Markets daily chart reflect the company's adaptation, where 7.57 is the current value of the metric. Brand scalability is supported by regular sales of consumables, while efficiency grows through the implementation of robotic lines and CAD/CAM 3D modeling systems.

XRAY Dentsply: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/15/2026

Analytical breakdowns for Dentsply Sirona Inc (XRAY)

- stock price and consensus target price:
Summary company analysis:Sirona Dental Systems (XRAY)
Manufactured products of Dentsply Sirona

This indicator correlates the total enterprise value with operating profit before depreciation and amortization, allowing for an assessment of the real value of assets while accounting for debt load and tax obligations. By analyzing the historical EV/EBITDA value, an investor can determine the efficiency of DENTSPLY SIRONA Inc. (XRAY) capital-intensive investments in high-tech R&D and the retention of a premium engineering staff, separating market noise from the fundamental value of this dental market leader.

Competitors of DENTSPLY SIRONA Inc.

Intuitive Surgical - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio danaher.com (DHR)|BDX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|STE (STERIS PLC) - Enterprise Value to Operating Income Before Depreciation|West Pharma Corp (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BAX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization masimo.com|Stevanato Group (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Teleflex (TFX)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista Holdings Corp NVST|Business Value to Operating Income Before Depreciation ICUI|LMAT: Enterprise Value to EBITDA Ratio|ATRC - EV/EBITDA Multiple|STAAR Surgical Co. (STAA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ChromaDex Corp.|ZIMV (zimvie.com) - EV/EBITDA Multiple|Company Value to EBITDA AngioDynamics Inc. ANGO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cerus (CERS)|Teknova - Enterprise Value to Operating Income Before Depreciation|Monogram Technologies - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio STSS (Sharps Technology, Inc.)|INFU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Utah Medical Products UTMD|KORU Medical (KRMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation NYXH|MBOT (Microbot Medical, Inc.) - EV/EBITDA Multiple|PDEX: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zentek Ltd. (ZTEK)|EV/EBITDA Multiple Elutia Inc. (ELUT)|EV/EBITDA Multiple MLSS (Milestone Scientific Inc)|Enterprise Value to EBITDA Multiple NEXGEL, Inc.|Retractable Technologies, Inc. - EV/EBITDA Multiple|HBIO - EV/EBITDA Multiple|FEMY (femasys.com) - Enterprise Value to EBITDA Ratio|Meihua Medical (MHUA) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio POAI|CJMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATRI|Enterprise Value to Operating Income Before Depreciation Ratio NURO